NOSIP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.725800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.707000E-01
Normal-vs-Stage2
7.956200E-01
Normal-vs-Stage3
8.740200E-01
Normal-vs-Stage4
7.310000E-01
Stage1-vs-Stage2
7.487200E-01
Stage1-vs-Stage3
8.257000E-01
Stage1-vs-Stage4
6.713000E-01
Stage2-vs-Stage3
6.197400E-01
Stage2-vs-Stage4
7.642400E-01
Stage3-vs-Stage4
6.401000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.750200E-01
Normal-vs-AfricanAmerican
4.890800E-01
Normal-vs-Asian
4.563200E-01
Caucasian-vs-AfricanAmerican
2.801800E-01
Caucasian-vs-Asian
2.425600E-01
AfricanAmerican-vs-Asian
8.539800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.847800E-01
Normal-vs-Female
9.246800E-01
Male-vs-Female
1.297380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.904400E-01
Normal-vs-Age(41-60Yrs)
9.376000E-01
Normal-vs-Age(61-80Yrs)
6.803000E-01
Normal-vs-Age(81-100Yrs)
5.375400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.842600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.225000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.568200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.501900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.451600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.012800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.355800E-01
Normal-vs-Daily Drinker
3.090000E-01
Normal-vs-Weekly Drinker
5.320400E-01
Normal-vs-Occasional Drinker
5.633600E-01
Normal-vs-Social Drinker
6.681000E-01
Non Drinker-vs-Daily Drinker
2.618400E-02
Non Drinker-vs-Weekly Drinker
2.937000E-01
Non Drinker-vs-Occasional Drinker
2.769000E-01
Non Drinker-vs-Social Drinker
1.915420E-01
Daily Drinker-vs-Weekly Drinker
4.315400E-01
Daily Drinker-vs-Occasional Drinker
2.492600E-01
Daily Drinker-vs-Social Drinker
1.108270E-02
Weekly Drinker-vs-Occasional Drinker
8.051200E-01
Weekly Drinker-vs-Social Drinker
8.603600E-02
Occasional Drinker-vs-Social Drinker
8.768200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.668800E-01
Normal-vs-Grade 2
9.218000E-01
Normal-vs-Grade 3
7.024800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.653600E-01
Grade 1-vs-Grade 3
2.968000E-01
Grade 1-vs-Grade 4
9.668800E-01
Grade 2-vs-Grade 3
2.108600E-01
Grade 2-vs-Grade 4
9.218000E-01
Grade 3-vs-Grade 4
7.024800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.526800E-01
Normal-vs-NonDiabetic
6.787200E-01
Diabetic-vs-NonDiabetic
3.383200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.236600E-01
Normal-vs-NoPancreatitis
6.627800E-01
Pancreatitis-vs-NoPancreatitis
6.095000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.886600E-01
Normal-vs-N1
8.725800E-01
N0-vs-N1
1.235380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.535800E-01
Normal-vs-TP53-NonMutant
6.178400E-01
TP53-Mutant-vs-TP53-NonMutant
7.815900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
